Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

breast cancer

"Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells" (2018) Sampayo, R.G.;Toscani, A.M.;Rubashkin, M.G. (...)Simian, M. Journal of Cell Biology. 217(8):2777-2798

"Comparative proteomics of soluble factors secreted by human breast adipose tissue from tumor and normal breast" (2018) Fletcher, S.J.;Hapon, M.B.;Callegari, E.A. (...)Pistone-Creydt, V. Oncotarget. 9(57):31007-31017

"Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells" (2017) Cambados, N.;Walther, T.;Nahmod, K. (...)Schere-Levy, C. Oncotarget. 8(51):88475-88487

"Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations" (2017) Luce, L.N.; Abbate, M.; Cotignola, J.; Giliberto, F. Oncotarget. 8(1):145-155

"Phytochemical Study of the Genus Salpichroa (Solanaceae), Chemotaxonomic Considerations, and Biological Evaluation in Prostate and Breast Cancer Cells" (2017) Basso, A.V.;Leiva González, S.;Barboza, G.E. (...)Nicotra, V.E. Chemistry and Biodiversity. 14(8)

"Predictive outcomes for HER2-enriched cancer using growth and metastasis signatures driven by SPARC" (2017) Guttlein, L.N.;Benedetti, L.G.;Fresno, C. (...)Podhajcer, O.L. Molecular Cancer Research. 15(3):304-316

"Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer" (2016) Blidner, A.G.; Mariño, K.V.; Rabinovich, G.A. Immunity. 44(6):1248-1250

"RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes" (2016) Recouvreux, M.S.;Grasso, E.N.;Echeverria, P.C. (...)Rubinstein, N. Oncotarget. 7(6):6552-6565

"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281

"21-hydroxy-6,19-epoxyprogesterone: A promising therapeutic agent and a molecular tool for deciphering glucocorticoid action" (2016) Pecci, A.; Alvarez, L.D.; Presman, D.M.; Burton, G. Mini-Reviews in Medicinal Chemistry. 16

"Improving information retrieval in functional analysis" (2016) Rodriguez, J.C.;González, G.A.;Fresno, C. (...)Fernández, E.A. Computers in Biology and Medicine. 79:10-20

"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154

"CtBP1 associates metabolic syndrome and breast carcinogenesis targeting multiple miRNAs" (2016) De Luca, P.;Dalton, G.N.;Scalise, G.D. (...)De Siervi, A. Oncotarget. 7(14):18798-18811

"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808

"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335

"The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor" (2015) Casa, A.J.;Hochbaum, D.;Sreekumar, S. (...)Lee, A.V. Molecular and Cellular Endocrinology. 415:76-86

"Exploring the molecular basis of action of ring D aromatic steroidal antiestrogens" (2015) Alvarez, L.D.; Veleiro, A.S.; Burton, G. Proteins: Structure, Function and Bioinformatics. 83(7):1297-1306

"Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52" (2014) Erlejman, A.G.;Lagadari, M.;Harris, D.C. (...)Galigniana, M.D. Current Protein and Peptide Science. 15(3):205-215

"The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy" (2014) Orqueda, A.J.;Dansey, M.V.;Español, A. (...)Pecci, A. Biochemical Pharmacology. 89(4):526-535

"Synthesis and biological evaluation of salpichrolide analogs as antiestrogenic agents" (2014) Sonego, J.M.;Rivero, E.M.;Gargiulo, L. (...)Burton, G. European Journal of Medicinal Chemistry. 82:233-241

"Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines" (2014) Cardama, G.A.;Comin, M.J.;Hornos, L. (...)Menna, P.L. Anti-Cancer Agents in Medicinal Chemistry. 14(6):840-851

"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290

"Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases" (2014) Martinez, L.M.;Vallone, V.B.F.;Labovsky, V. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 31(2):213-232

"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558

"Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions" (2013) Spallanzani, R.G.;Dalotto-Moreno, T.;Raffo Iraolagoitia, X.L. (...)Zwirner, N.W. Cancer Immunology, Immunotherapy. 62(12):1781-1795

"Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis" (2013) Fernández Vallone, V.B.;Hofer, E.L.;Choi, H. (...)Chasseing, N.A. Clinical and Experimental Metastasis. 30(3):317-332

"Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease" (2013) Dalotto-Moreno, T.;Croci, D.O.;Cerliani, J.P. (...)Salatino, M. Cancer Research. 73(3):1107-1117

"Anti-tumor effect of SLPI on mammary but not colon tumor growth" (2013) Amiano, N.O.;Costa, M.J.;Reiteri, R.M. (...)Chuluyan, H.E. Journal of Cellular Physiology. 228(2):469-475

"Cellular and molecular specificity of pituitary gland physiology" (2012) Perez-Castro, C.;Renner, U.;Haedo, M.R. (...)Arzt, E. Physiological Reviews. 92(1):1-38

"PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer" (2012) Riggio, M.;Polo, M.L.;Blaustein, M. (...)Novaro, V. Carcinogenesis. 33(3):509-518

"GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration" (2012) Scolz, M.;Widlund, P.O.;Piazza, S. (...)Bird, A.W. PLoS ONE. 7(12)

"Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes" (2012) Robaldo, L.;Izzo, F.;Dellafiore, M. (...)Iribarren, A.M. Bioorganic and Medicinal Chemistry. 20(8):2581-2586

"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320

"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein" (2012) Goddio, M.V.;Gattelli, A.;Slomiansky, V. (...)Kordon, E.C. Breast Cancer Research and Treatment. 135(3):749-758

"Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines" (2012) Labovsky, V.;Vallone, V.B.F.;Martinez, L.M. (...)Chasseing, N.A. Cancer Cell International. 12

"Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone" (2011) Alvarez, L.D.;Dansey, M.V.;Martí, M.A. (...)Burton, G. Bioorganic and Medicinal Chemistry. 19(5):1683-1691

"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880

"Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from laminaria saccharina brown seaweed" (2011) Croci, D.O.;Cumashi, A.;Ushakova, N.A. (...)Nifantiev, N.E. PLoS ONE. 6(2)

"p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior" (2011) Rosenthal, D.T.;Iyer, H.;Escudero, S. (...)Merajver, S.D. Cancer Research. 71(20):6338-6349

"Role of histamine H4 receptor in breast cancer cell proliferation" (2011) Medina, V.A.;Brenzoni, P.G.;Lamas, D.J.M. (...)Rivera, E.S. Frontiers in Bioscience - Elite. 3 E(3):1042-1060

"Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow" (2010) Hofer, E.L.;Labovsky, V.;La Russa, V. (...)Chasseing, N.A. Stem Cells and Development. 19(3):359-369

"Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth" (2009) Proietti, C.J.;Rosemblit, C.;Beguelin, W. (...)Elizalde, P.V. Molecular and Cellular Biology. 29(5):1249-1265

"Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas" (2009) Labeur, M.; Paez-Pereda, M.; Arzt, E.; Stalla, G.K. Reviews in Endocrine and Metabolic Disorders. 10(2):103-109

"Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas" (2009) Wargon, V.;Helguero, L.A.;Bolado, J. (...)Lanari, C. Breast Cancer Research and Treatment. 116(3):449-460

"MMTV-induced pregnancy-dependent mammary tumors: Early history and new perspectives" (2008) Kordon, E.C. Journal of Mammary Gland Biology and Neoplasia. 13(3):289-297

"Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy" (2008) Vittar, N.B.R.;Prucca, C.G.;Strassert, C. (...)Rivarola, V.A. International Journal of Biochemistry and Cell Biology. 40(10):2192-2205

"Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways" (2007) Carnevale, R.P.;Proietti, C.J.;Salatino, M. (...)Elizalde, P.V. Molecular Endocrinology. 21(6):1335-1358

"Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment" (2007) Montero Girard, G.;Vanzulli, S.I.;Cerliani, J.P. (...)Lanari, C. Breast Cancer Research. 9(2)

"Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation" (2006) Salatino, M.;Beguelin, W.;Peters, M.G. (...)Elizalde, P.V. Oncogene. 25(59):7723-7739

"Selection of early-occurring mutations dictates hormone-independent progression in mouse mammary tumor lines" (2006) Gattelli, A.;Zimberlin, M.N.;Meiss, R.P. (...)Kordon, E.C. Journal of Virology. 80(22):11409-11415

"Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model" (2005) Fabris, V.T.;Benavides, F.;Conti, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 161(2):130-139

"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells" (2005) Proietti, C.;Salatino, M.;Rosemblit, C. (...)Elizalde, P.V. Molecular and Cellular Biology. 25(12):4826-4840

"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134

"Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleptides to type I insulin-like growth factor receptor rnRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity" (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Oncogene. 23(30):5161-5174

"Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells" (2003) Labriola, L.;Salatino, M.;Proietti, C.J. (...)Elizalde, P.V. Molecular and Cellular Biology. 23(3):1095-1111

"Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients" (2002) Honegger, A.E.;Hofer, E.L.;Barañao, R.I. (...)Chasseing, N.A. Annals of Hematology. 81(2):80-85

"α2-adrenergic effect on human breast cancer MCF-7 cells" (1999) Vázquez, S.M.; Pignataro, O.; Luthy, I.A. Breast Cancer Research and Treatment. 55(1):41-49

"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170

"Bone marrow fibroblastic progenitors in patients with advanced breast cancer" (1997) Chasseing, N.A.;Trejo, Y.G.;Bordenave, R.H. (...)Rumi, L.S. Breast Cancer Research and Treatment. 45(3):211-218

"B21 anti-breast Ca" (1997) Baldi, A. Hybridoma. 16(3):302

"Characterization of the ETSA-21 antigen, a glycosylphosphatidyl-inositol anchor glycoprotein identified in breast cancer cells using monoclonal antibody B21" (1997) Annibali, N.V.; Baldi, A. Hybridoma. 16(2):139-145

"Prazosin and stress effect on tumoral growth of 7,12-dimethylbenz[A]anthracene-induced rat mammary tumors" (1996) Wendel, V.;Maris Vazquez, S.;Durante, P.C. (...)Luthy, I.A. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana. 46(4):277-285

"Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells" (1995) Ballaré, C.; Barrio, M.; Portela, P.; Mordoh, J. Cancer Immunology Immunotherapy. 41(1):15-22

"Establishment and characterization of a new metastatic cell line (M3MC) derived from a murine mammary tumor" (1994) Lucero Gritti, M.F.; Garcia De Palazzo, I.E.; Meiss, R.P.; Bonfil, R.D. Journal of Experimental and Clinical Cancer Research. 13(2):113-119

"Chemiluminescence production by neutrophils and immune complex levels in cancer patients" (1993) Chasseing, N.A.;Barañao, R.I.;Fernández, O. (...)Rumi, L.S. Cancer Investigation. 11(5):517-522

"Marker Expression and Differentiation in Human Breast Cancer" (1993) BALLARE, C.;BRAVO, A.I.;TURCHI, V. (...)MORDOH, J. Annals of the New York Academy of Sciences. 698(1):143-147

"Uroporhyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumor-bearing mouse" (1992) Navone, N.M.; Afonso, S.G.; Polo, C.F.; del C. Battle, A.M. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 102(1):87-92

"The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer" (1991) Ballare, C.;Bravo, A.I.;Sorin, I. (...)Mordoh, J. Cancer. 67(5):1352-1358

"Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor" (1991) Bover, L.;Barrio, M.;Slavutsky, I. (...)Mordoh, J. Breast Cancer Research and Treatment. 19(1):47-56

"Heme regulation in mouse mammary carcinoma and liver of tumor bearing mice-I. Effect of allyl-isopropylacetamide and veronal on δ -aminolevulinate synthetase, cytochrome P-450 and cytochrome oxidase" (1990) Navone, N.M.; Polo, C.F.; Dinger, R.M.; Del C. Batlle, A.M. International Journal of Biochemistry. 22(9):1005-1008

"Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells" (1990) Bustamante, J.; Galleano, M.; Medrano, E.E.; Boveris, A. Breast Cancer Research and Treatment. 17(2):145-153

"Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymic activity levels" (1990) Navone, N.M.;Polo, C.F.;Frisardi, A.L. (...)del C. Baille, a.M. International Journal of Biochemistry. 22(12):1407-1411

"Mouse mammary carcinoma δ-aminolevulinate dehydratase" (1990) Navone, N.M.; Polo, C.F.; Frisardi, A.L.; Batlle, A.M.D.C. Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 96(4):729-731

"Growth factors and hormones which affect survival, growth, and differentiation of the MCF-7 stem cells and their descendants" (1989) Resnicoff, M.; Medrano, E.E. Experimental Cell Research. 181(1):116-125

"Porphyrin bioasynthesis in human breast cancer. Preliminary mimetic in vitro studies" (1988) Navone, N.M.;Frisardi, A.L.;Resnik, E.R. (...)Polo, C.F. Medical Science Research. 16(2):61-62

"Mitoxantrone affects topoisomerase activities in human breast cancer cells" (1986) Crespi, M.D.; Ivanier, S.E.; Genovese, J.; Baldi, A. Biochemical and Biophysical Research Communications. 136(2):521-528

"Dolichol-sugar derivative synthesis in human breast cancer cell line (T47D). Effects of estrogens and antiestrogens" (1985) Santa Cruz, A.R.; Medrano, E.E.; Baldi, A. Biochemical and Biophysical Research Communications. 126(1):382-388

"Transfer of oligosaccharide from oligosaccharide pyrophosphoryl dolichol to endogenous acceptor proteins in human breast malignant and normal tissues" (1985) Santa Cruz, A.R.; Baldi, A. Experientia. 41(7):928-929

"Suppressor activity induced by Concanavalin A in peripheral lymphocytes from patients with solid malignant tumors " (1983) Garcia, M.S.; Baranao, R.I.; Fernandez, O.; Rumi, L.S. Acta Physiologica Latino-Americana. 33(1):19-24

"Transcriptional features of fractionated human breast tumor chromatin" (1979) Thierbach, L.I.A.; Rosemblit, N.; Pahn, C.R.; Baldi, A. Acta Physiologica Latino-Americana. 29(1):81-85